Erik R Gustafson

US Patent:

7211570, May 1, 2007

Filed:

Dec 19, 2002

Appl. No.:

10/326444

Inventors:

Raymond F. Schinazi - Decatur GA, US
Junxing Shi - Duluth GA, US
Joyce D. Fingeroth - Sudbury MA, US
Erik Gustafson - Norwood MA, US

Assignee:

Pharmasset, Inc. - Princeton NJ
Emory University - Atlanta GA
Beth Israel Deaconess Medical Center - Boston MA

International Classification:

A61K 31/70
A01N 43/06
A01N 43/26
A01N 47/10
A01N 43/54

US Classification:

514 49, 514444, 514463, 514476, 514256

Abstract:

A method and composition for the treatment, prevention and/or prophylaxis of a host, and in particular, a human, infected with Epstein-Barr virus (EBV), is provided that includes administering an effective amount of a 5-substituted uracil nucleoside or its pharmaceutically acceptable salt or prodrug, optionally in a pharmaceutically acceptable diluent or excipient.

US Patent:

7638502, Dec 29, 2009

Filed:

Dec 4, 2006

Appl. No.:

11/633651

Inventors:

Raymond F. Schinazi - Decatur GA, US
Junxing Shi - Duluth GA, US
Joyce D. Fingeroth - Sudbury MA, US
Erik Gustafson - Norwood MA, US

Assignee:

Pharmasset, Inc. - Princeton NJ
Beth Israel Deaconess Medical Center - Boston MA
Emory University - Atlanta GA

International Classification:

A01N 43/04
A61K 31/70

US Classification:

514 50, 514 43, 514 49

Abstract:

A method and composition for the treatment, prevention and/or prophylaxis of a host, and in particular, a human, infected with Epstein-Barr virus (EBV), is provided that includes administering an effective amount of a 5-substituted uracil nucleoside or its pharmaceutically acceptable salt or prodrug, optionally in a pharmaceutically acceptable diluent or excipient.

US Patent:

20100168052, Jul 1, 2010

Filed:

Dec 28, 2009

Appl. No.:

12/647959

Inventors:

Raymond F. Schinazi - Decatur GA, US
Junxing Shi - Duluth GA, US
Erik Gustafson - Norwood MA, US
Joyce D. Fingeroth - Sudbury MA, US

Assignee:

Pharmasset, Inc. - Princeton NJ
EMORY UNIVERSITY - Atlanta GA
BETH ISRAEL DEACONESS MEDICAL CENTER - Boston MA

International Classification:

A61K 31/7034
A61K 31/513
A61P 35/00
A61P 31/00
C12N 5/073

US Classification:

514 50, 514274, 435369

Abstract:

A method and composition for the treatment, prevention and/or prophylaxis of a host, and in particular, a human, infected with Epstein-Barr virus (EBV), is provided that includes administering an effective amount of a 5-substituted uracil nucleoside or its pharmaceutically acceptable salt or prodrug, optionally in a pharmaceutically acceptable diluent or excipient.

US Patent:

20130232997, Sep 12, 2013

Filed:

Mar 6, 2012

Appl. No.:

13/413104

Inventors:

Erik Gustafson - Waleska GA, US

International Classification:

F17C 7/04

US Classification:

62 481

Abstract:

Described herein are systems and methods for cryogenic fluid delivery. The systems may include a pressure vessel containing a cryogenic fluid formed of liquid and vapor that is connected to a use device via a withdrawal line. The withdrawal line connects to the cryogenic fluid in the pressure vessel via two routes, a liquid tube and a vapor line. The vapor line may include a back-pressure regulator that opens the vapor line depending on pressure in the system. The withdrawal line may include a pressure relief valve that exerts pressure on the liquid tube. A bypass line may connect the withdrawal line to the liquid tube. The bypass line has a check valve that permits free flow of cryogen from the withdrawal line to the liquid tube via the bypass line while prohibiting cryogen flow from the pressure vessel through the bypass line. The methods employ the systems described herein.

US Patent:

20140075965, Mar 20, 2014

Filed:

Sep 19, 2012

Appl. No.:

13/623048

Inventors:

Jeff Patelczyk - Ball Ground GA, US
Erik Gustafson - Ball Ground GA, US

International Classification:

F17C 7/04

US Classification:

62 503, 62 501, 62 502

Abstract:

Described herein are at least systems and methods for cryogenic fluid delivery which utilize pumpless delivery of cryogenic fluid. The systems and methods utilize hydraulic pressure, saturation pressure, or a combination of both hydraulic pressure and saturation pressure to deliver cryogen to a use device, such as an engine.

US Patent:

20220282837, Sep 8, 2022

Filed:

Mar 4, 2022

Appl. No.:

17/686842

Inventors:

- Ball Ground GA, US
Erik Gustafson - Woodstock GA, US

International Classification:

F17C 13/04
F17C 5/04

Abstract:

A nozzle includes a nozzle bayonet with a warm seal positioned at a distal end and a nose seal positioned at a proximal end so that a distal passage is defined between the warm and nose seals. The nozzle also includes a nozzle poppet valve. Purge and vent lines are in fluid communication with the distal passage. A receptacle includes a receptacle poppet valve, a receptacle inner tube and a receptacle outer tube with a receptacle insulation space defined therebetween. A coupling space is defined between an outer casing and the receptacle outer tube. The receptacle coupling space receives the nozzle bayonet. The receptacle sequentially engages the warm seal and the nose seal of the nozzle during insertion of the nozzle bayonet into the receptacle coupling space with the nozzle and receptacle poppets engaging to open the nozzle and receptacle poppet valves when the nozzle bayonet is fully inserted into the receptacle coupling space.

US Patent:

20200270708, Aug 27, 2020

Filed:

Feb 20, 2020

Appl. No.:

16/796832

Inventors:

- Alpharetta GA, US
Lori Bennett - Alpharetta GA, US
Liquan Yang - Lilburn GA, US
Marianna Agassandian - Alpharetta GA, US
Rama Murthy Sakamuri - Cumming GA, US
Erik Gustafson - Alpharetta GA, US
Lilly Kong - Covina CA, US
Kiran Madanahally Divakar - Alpharetta GA, US

International Classification:

C12Q 1/6895
C12Q 1/689
C12Q 1/686

Abstract:

Provided herein is a real-time PCR-based method of detecting, in a sample, an agent causing onychodystrophy, wherein the agent causing onychodystrophy belongs to a secondary clade member including one or more primary clade members. Also provided are compositions and kits that finds use in implementing the present method.

US Patent:

20190277450, Sep 12, 2019

Filed:

Mar 6, 2019

Appl. No.:

16/293985

Inventors:

- Ball Ground GA, US
Erik Gustafson - Waleska GA, US

International Classification:

F17C 7/02
F17C 5/02

Abstract:

A system for transferring cryogenic fluid from a dispensing tank to a receiving tank is disclosed. The dispensing tank stores a supply of cryogenic liquid with a dispensing tank headspace above the liquid. A compressor has an inlet connected to the headspace of a receiving tank and an outlet connected to the headspace of the dispensing tank. A liquid transfer line is in fluid communication with the liquid side of the dispensing tank and the receiving tank. Cryogenic liquid is transferred from the dispensing tank to the receiving tank when the compressor is activated so as to transfer vapor from the headspace of the receiving tank to the headspace of the dispensing tank to create a pressure differential between the dispensing and receiving tanks.